For many people diagnosed with heart valve disease, the first question is simple: Will the surgery save my life?
Today, thanks to advances in cardiac surgery, that question is increasingly being followed by another.
How will this decision affect the rest of my life?
As people live longer and more patients undergo heart valve surgery earlier in life, doctors are rethinking how they approach treatment. The focus is no longer solely on a successful operation. It is about helping patients live well for decades, preserving future treatment options, reducing the need for repeat surgeries where possible, and enabling people to continue doing the things that matter most to them. This changing philosophy, known as lifetime valve management, was a key topic of discussion among more than 120 cardiac surgeons from 10 countries who recently gathered in Bangkok to share the latest evidence and clinical experience in heart valve care.
A Different Generation of Heart Valve Patients
Heart valve disease affects millions of people worldwide and becomes more common with age. However, advances in diagnosis and treatment mean that many patients are now receiving surgery earlier and living much longer after their procedures. For younger patients, surgery is no longer viewed as a one-time event. Instead, it marks the beginning of a lifelong journey of care. Every decision, from the type of valve implanted to the surgical technique used, can influence future treatment options if another intervention becomes necessary years later.
"This is one of the biggest shifts we have seen in cardiac surgery," said Prof. Dato' Seri Dr. Jeffrey Jeswant Dillon, Senior Consultant Cardiothoracic Surgeon at the National Heart Institute (IJN), Malaysia. "We are increasingly thinking beyond today's operation. Our goal is to help patients maintain good health and preserve treatment options throughout their lifetime."
Looking Beyond Survival
Historically, success in heart valve surgery was measured by immediate outcomes such as survival, recovery and symptom relief. While these remain critically important, clinicians are now also considering longer-term questions.
How long is the replacement valve likely to last?
Will the patient require lifelong blood-thinning medication?
If another procedure becomes necessary in the future, what treatment options will still be available?
These conversations have become especially relevant because many patients can now expect to live for several decades after their first valve replacement. "Every decision we make today may have implications many years down the road," explained Dr. Vinayak (Vinnie) Bapat, Chair of Cardiothoracic Surgery at the Valve Science Center, Allina Health Minneapolis Heart Institute in the United States. "Having long-term evidence allows us to better understand how different treatment strategies may perform over a patient's lifetime."
When Research Meets Real Life
Clinical research provides important evidence for doctors, but it is often patient experiences that reveal what those findings truly mean. One patient from New Zealand shared how undergoing heart valve replacement in 2018 allowed him to return to an active lifestyle. Choosing a tissue valve was an important personal decision because he hoped to avoid lifelong anticoagulation therapy, giving him greater flexibility in his daily life.
Another patient from Thailand described how reducing the likelihood of another major surgery was central to her decision-making. Remaining healthy meant she could continue caring for her family, a priority that shaped her treatment choices as much as any clinical consideration. Their stories reflect a reality faced by many patients living with heart valve disease. Success is measured not only in years gained, but in the ability to continue working, travelling, exercising, caring for loved ones and enjoying everyday life.
The Growing Importance of Long-Term Evidence
One of the themes emerging from discussions among cardiac surgeons is the increasing value of long-term clinical data.In medicine, evidence that follows patients over 10 years or more is relatively uncommon but particularly valuable. It helps doctors understand how treatments perform over time and supports more informed conversations with patients about what they may expect in the years ahead.
Rather than focusing only on the immediate success of surgery, clinicians are increasingly using long-term evidence to guide decisions that consider the patient's entire healthcare journey. For patients, this means conversations with their healthcare team are becoming more personalised. The best treatment option is not necessarily the same for everyone. Age, lifestyle, overall health, family responsibilities and personal preferences all play an important role.
Questions Patients Should Ask
If you have been diagnosed with heart valve disease or are considering surgery, experts encourage patients to take an active role in understanding their treatment options.
Some questions worth discussing with your cardiologist or cardiac surgeon include:
What type of valve is most appropriate for my age and health?
How long is the valve expected to last?
Will I need lifelong blood-thinning medication?
If I need another procedure in the future, what options would be available?
How will this surgery affect my daily activities, work and quality of life?
What follow-up care will I need over the coming years?
There is rarely a single right answer. Instead, the best decisions are made when patients and healthcare professionals work together, balancing clinical evidence with personal priorities and long-term goals.
Planning for the Future
Advances in heart valve surgery have transformed outcomes for countless patients across the world. Yet as life expectancy continues to increase, success is no longer measured solely by surviving an operation. It is measured by helping people live well afterwards.
For today's heart valve patients, the first operation is often just one chapter in a much longer story. The challenge for modern medicine is not simply replacing a damaged valve, but planning for a lifetime of care that allows patients to continue living the lives they want.
This article draws on discussions and expert presentations shared during the RESILIA Summit 2026 in Bangkok, and brought together cardiac surgeons from across the Asia-Pacific region to discuss advances in heart valve surgery and long-term patient care.
